| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/26/2006 | US20060018905 Methods for treating systemic lupus erythematosus using anti-TNF antibodies and fragments thereof |
| 01/26/2006 | US20060018903 Tumor necrosis factors (TNF); site-directed mutagenesis, genetic deletions; monoclonal antibodies with decreased immunogenicity and lymphocyte epitopes; major histocompatibility complex binding ligands; for treatment of rheumatoid arthritis and Crohn's disease |
| 01/26/2006 | US20060018898 Antibody variants |
| 01/26/2006 | US20060018896 Methods for treating conditions associated with lectin-dependent complement activation |
| 01/26/2006 | US20060018895 Murine monoclonal anti-idiotype antibody 11D10 and methods of use thereof |
| 01/26/2006 | US20060018894 Administration of enoxoparin sodium to patients 75 years and older with ST-segment elevation myocardial infarction |
| 01/26/2006 | US20060018893 Method for determining modulation of P110delta activity |
| 01/26/2006 | US20060018892 nucleic acid molecule comprising nucleotide sequences, that code fro single chain proteins which are serine protease inhibitors, used for prophylaxis of emphysema, cirrhosis, hepatitis, blood disorders, tumors and tumor metastasis |
| 01/26/2006 | US20060018891 Soft gel capsule, beta-carotene; vitamin E; yellow beeswax;a mixture of mono-, di, tri-glycerides of 16 to 18 carbon chain length and polyglycerol oleate; rice bran oil |
| 01/26/2006 | US20060018887 Enhanced adipose tissue |
| 01/26/2006 | US20060018886 culturing a multilayer of human embryonic stem cells, for a sufficient time to allow for the appearance of putative cells comprising brown pigment dispersed within their cytoplasm, culturing the putative cells to form a cell monolayer containing cells that are Pax6 negative and bestrophin positive |
| 01/26/2006 | US20060018884 Method for treating human tumor cells with a newcastle disease virus strain and a chemotherapeutic agent |
| 01/26/2006 | US20060018881 Coordinate in vivo gene expression |
| 01/26/2006 | US20060018880 Methods and compositions for delivery of an enhanced response to antigenic substrates |
| 01/26/2006 | US20060018876 Treatment of diseases caused by viral infection |
| 01/26/2006 | US20060018875 Interferon compositions and methods of use thereof |
| 01/26/2006 | US20060018874 Fatty acid formulations for oral delivery of proteins and peptides, and uses thereof |
| 01/26/2006 | US20060018873 inducing in a patient, at least one activity of IL-2 selected from increasing humoral immune responses and increasing cellular immune responses, by administering to said patient a therapeutically effective amount of a peptide sufficient to induce the activity |
| 01/26/2006 | US20060018859 Modified human serum albumin with reduced or eliminated affinity to chemical or biological contaminants at Cys 34 |
| 01/26/2006 | US20060018844 Botulinum toxin dental therapy for angular cheilosis |
| 01/26/2006 | DE102004030227A1 Treatment of diseases (e.g. proliferative diseases of tumor cells, ophthalmic diseases and skin diseases) associated with angiogenesis comprises administration of carbamide compounds |
| 01/26/2006 | CA2612303A1 Anti-glycated cd59 antibodies and uses thereof |
| 01/26/2006 | CA2579726A1 Macrocyclic modulators of the ghrelin receptor |
| 01/26/2006 | CA2574665A1 Therapeutic and diagnostic agents |
| 01/26/2006 | CA2574558A1 Anti-hypertensive functional food products |
| 01/26/2006 | CA2574548A1 Use of hmgb1 for wound healing |
| 01/26/2006 | CA2574477A1 Alpha-defensins as anthrax immunotherapeutics |
| 01/26/2006 | CA2574423A1 Preparation for use of aspartate and vitamin b12 or biotin for regulating ketone bodies |
| 01/26/2006 | CA2574360A1 A preparation for use of aspartate for regulating glucose levels in blood |
| 01/26/2006 | CA2574354A1 Imidazole and thiazole derivatives as antiviral agents |
| 01/26/2006 | CA2574232A1 Use of compounds containing thiol groups as an efflux pump inhibitor |
| 01/26/2006 | CA2574196A1 Use of haptoglobin and hemoglobin to modulate na ion transport in a vertebrate |
| 01/26/2006 | CA2574085A1 Gonadotropin releasing hormone antagonists |
| 01/26/2006 | CA2574060A1 Immune modulating compounds from fungi |
| 01/26/2006 | CA2572832A1 Bacteriophage and prophage proteins in cancer gene therapy |
| 01/26/2006 | CA2572816A1 Use of lamin b1 nuclear antigen, fragments and compositions thereof, for inhibiting or reducing a trombotic event |
| 01/26/2006 | CA2572558A1 Methods of treating neurological conditions with hematopoeitic growth factors |
| 01/26/2006 | CA2571542A1 Aequorin-containing compositions and methods of using same |
| 01/26/2006 | CA2571237A1 Methods of using macrocyclic modulators of the ghrelin receptor |
| 01/26/2006 | CA2571168A1 Mhc i-binding ssx-241-49 variants |
| 01/26/2006 | CA2570960A1 Compositions and methods for treating central precocious puberty |
| 01/26/2006 | CA2570471A1 Use of apo2l receptor agonists and nk cells or nk cell activators |
| 01/26/2006 | CA2569191A1 C-met kinase binding proteins |
| 01/26/2006 | CA2568534A1 Vegf inhibitors for the treatment of malignant pleural effusion |
| 01/26/2006 | CA2553065A1 New pharmaceutical compositions based on fluorenecarboxyclic acid esters and soluble tnf receptor fusion proteins |
| 01/25/2006 | EP1619498A2 Method of screening remedy for heart disease and medicinal composition for treating heart disease |
| 01/25/2006 | EP1619254A1 Transfer of mRNA using polycationic compounds |
| 01/25/2006 | EP1619250A1 WSX receptor and ligands |
| 01/25/2006 | EP1619244A1 Method for inducing neural differentiation |
| 01/25/2006 | EP1619208A1 Chaperonine-target protein complex, method of producing the same, method of stabilizing target protein, method of immobilizing target protein, method of analyzing the structure of target protein, sustained-release preparation and method of producing antibody against target protein |
| 01/25/2006 | EP1619205A1 Fibrin citrulline derivatives and their use for diagnosing or treating rheumatoid arthritis |
| 01/25/2006 | EP1619204A1 PTH-like peptides |
| 01/25/2006 | EP1619203A1 Galectin 9-inducing factor |
| 01/25/2006 | EP1619202A2 immunotherapeutic methods using epitopes of wt-1 and gata-1 |
| 01/25/2006 | EP1618898A2 Methods for regulating angiogenesis |
| 01/25/2006 | EP1618892A1 Instrument for inducing cytokine and method of inducing cytokine |
| 01/25/2006 | EP1618887A1 Clearance of polyols from the body |
| 01/25/2006 | EP1618886A1 Bacteriophage and prophage proteins in cancer gene therapy |
| 01/25/2006 | EP1618884A1 Instrument for inducing cytokine and method of inducing cytokine |
| 01/25/2006 | EP1618874A2 Prevention of hiv-1 infection by inhibition of rho-mediated reorganisation and/or content alteration of cell membrane raft domains |
| 01/25/2006 | EP1618801A1 Phaseolamin compositions and methods for using the same |
| 01/25/2006 | EP1618212A1 Mutations in the human pcsk9 gene associated to hypercholesterolemia |
| 01/25/2006 | EP1618205A2 Methods of treating diseases responsive to induction of apoptosis and screening assays |
| 01/25/2006 | EP1618203A2 Methods of assaying for cell cycle modulators using components of the ubiquitin ligation cascade |
| 01/25/2006 | EP1618201A1 Vp2 - modified raav vectors and uses thereof |
| 01/25/2006 | EP1618197A2 Canine ghrh gene, polypeptides and methods of use |
| 01/25/2006 | EP1618196A2 Dna-based aptamers for human cathepsin g |
| 01/25/2006 | EP1618195A2 Method for selective inhibition of human n-myc gene in n-myc expressing tumors through antisense and antigen peptido-nucleic acids (pna) |
| 01/25/2006 | EP1618192A1 Human alkaline sphingomyelinase and use thereof |
| 01/25/2006 | EP1618184A2 Epha2, hypoproliferative cell disorders and epithelial and endothelial reconstitution |
| 01/25/2006 | EP1618179A2 Polymer-conjugated glycosylated neublastin |
| 01/25/2006 | EP1618130A2 Therapeutic cancer vaccine |
| 01/25/2006 | EP1618129A2 Beta-amyloid inhibitors and use thereof |
| 01/25/2006 | EP1618127A2 The severe acute respiratory syndrome coronavirus |
| 01/25/2006 | EP1618125A1 Vitamin c derivatives with peptide, preparation method thereof and composition comprising the same |
| 01/25/2006 | EP1618124A2 Prophylactic and therapeutic benefits of new class of immune stimulating peptides |
| 01/25/2006 | EP1617875A1 Novel use of aim3 acting as a tumor suppressor |
| 01/25/2006 | EP1617868A1 Vav inhibition in graft rejection |
| 01/25/2006 | EP1617863A2 Compositions and methods for wt1 specific immunotherapy |
| 01/25/2006 | EP1617862A2 Botulinum neurotoxin for treating tics and obsessive compulsive behaviors |
| 01/25/2006 | EP1617861A2 Human serum albumin-free stabilised interferon liquid formulations |
| 01/25/2006 | EP1617860A2 Biodegradable glucosaminemuramyl peptides for apoptosis modulation |
| 01/25/2006 | EP1617859A1 Methods and compositions using gonadotropin hormone releasing hormone |
| 01/25/2006 | EP1617858A2 Use of active ingredients for preventing or treating viral illnesses, and test system for discovering such active ingredients |
| 01/25/2006 | EP1617857A2 Pharmaceutical compositions for treating painful neuropathy and methods of treating same |
| 01/25/2006 | EP1617856A2 Somatostatin-dopamine chimeric analogs |
| 01/25/2006 | EP1617855A2 Antimicrobial peptide and methods of use thereof |
| 01/25/2006 | EP1617854A2 Biologically active native biomatrix composition |
| 01/25/2006 | EP1617845A2 Compositions and methods for induction of opioid receptors |
| 01/25/2006 | EP1617805A2 Methods of preventing or treating respiratory conditions |
| 01/25/2006 | EP1617802A2 Cngh0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses. |
| 01/25/2006 | EP1617799A2 Hemophilia treatment by inhalation of coagulation factors |
| 01/25/2006 | EP1617785A2 Pharmaceutical compositions releasing their active agents from a buccal or sublingual location to overcome an absorption window problem |
| 01/25/2006 | EP1490692B1 Diagnostic and therapeutic use of caps |
| 01/25/2006 | EP1461071A4 Muscle transcription factors |
| 01/25/2006 | EP1392241A4 System for osmotic delivery of pharmaceutically active agents |
| 01/25/2006 | EP1144650B1 Goodpasture antigen binding protein |
| 01/25/2006 | EP1144000B1 New dialysis method |
| 01/25/2006 | EP1080202B1 Convection-enhanced delivery of aav vectors encoding aadc |
| 01/25/2006 | EP1051495B1 Recombinant mistletoe lectines |